Imidazopyridinones as p38 map kinase inhibitors

US6984646B2 · kind B2 · utility

Assignee

• BAYER HELTHCARE AG · DE

Inventors

• Cristina Alonso-Alija · Haan, DE
• Martin Michels · Solingen, DE
• Hartmut Schirok · Wuppertal, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Sara Dodd · Huntingdon, GB
• Mary F. Fitzgerald · Yarnton, GB
• John Bell · Chapel Hill, US
• Andrew Gill · Slough, GB

Key dates

• Filing date: Jul 15, 2002
• Grant date: Jan 10, 2006
• Expiry date: Aug 19, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to imidazopyridinones of the formula wherein the groups R1, R2, R3, and R4 are as defined in claim 1, to the process for their preparation, to pharmaceutical compositions containing them, and to a method of using them for treatment of chronic inflammatory processes in humans or animals.